These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33876860)

  • 1. Complications and failure modes of coronary embolic protection devices: Insights from the MAUDE database.
    Megaly M; Morcos R; Khalil C; Garcia S; Basir M; Maini B; Khalili H; Burke MN; Alaswad K; Brilakis ES
    Catheter Cardiovasc Interv; 2022 Feb; 99(2):405-410. PubMed ID: 33876860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.
    Khalid N; Javed H; Rogers T; Hashim H; Shlofmitz E; Chen Y; Khan JM; Musallam A; Torguson R; Bernardo NL; Waksman R
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):157-164. PubMed ID: 30985082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Flow Impairment during Carotid Artery Stenting Using Two Types of Eccentric Filter Embolic Protection Devices.
    Nii K; Tsutsumi M; Maeda H; Aikawa H; Inoue R; Eto A; Sakamoto K; Mitsutake T; Hanada H; Kazekawa K
    Neurol Med Chir (Tokyo); 2016 Dec; 56(12):759-765. PubMed ID: 27319302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
    JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of embolic protection devices in ostial saphenous vein graft lesions.
    Abdel-Karim AR; Papayannis AC; Mahmood A; Michael TT; Rangan BV; Makke L; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1120-6. PubMed ID: 22422709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary approaches to saphenous vein graft interventions: a survey of 275 interventional cardiologists.
    Mahmood A; Khair T; Abdel-karim AR; Papayannis A; Xu H; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):834-42. PubMed ID: 21538790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience.
    Golwala H; Hawkins BM; Stavrakis S; Abu-Fadel MS
    J Invasive Cardiol; 2012 Jan; 24(1):1-3. PubMed ID: 22210580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices.
    Shoaib A; Kinnaird T; Curzen N; Ludman P; Smith D; Khoo CW; Kontopantelis E; Rashid M; Mohamed M; Nolan J; Zaman A; Mamas MA; ;
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2286-2295. PubMed ID: 31753300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia.
    Mendes BC; Oderich GS; Tallarita T; Kanamori KS; Kalra M; DeMartino RR; Shuja F; Johnstone JK
    J Vasc Surg; 2018 Oct; 68(4):1071-1078. PubMed ID: 29685508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Perils of Buddy Wire Use With a Filterwire.
    Gutierrez A; Chugh Y; Kostantinis S; Brilakis ES
    Cardiovasc Revasc Med; 2022 Jul; 40S():214-217. PubMed ID: 35086774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries.
    Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C
    Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Low Rate of New Brain Lesions After Vulnerable Carotid Artery Stenting Cases Using Only FilterWire EZ as Distal Embolic Protection.
    Ishida A; Asakuno K; Shiramizu H; Yoshimoto H; Nakase K; Kato M; Matsuo S
    World Neurosurg; 2020 Sep; 141():e145-e150. PubMed ID: 32407920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
    Halkin A; Masud AZ; Rogers C; Hermiller J; Feldman R; Hall P; Haber RH; Cambier PA; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA; Mehran R; Stone GW
    Am Heart J; 2006 Apr; 151(4):915.e1-7. PubMed ID: 16569562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device.
    Porto I; Belloni F; Niccoli G; Larosa C; Leone AM; Burzotta F; Trani C; De Maria GL; Hamilton-Craig C; Crea F
    EuroIntervention; 2011 Dec; 7(8):955-61. PubMed ID: 22157481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important Notes for Preventing Entrapment of Distal Filter-based Embolic Protection Device in Carotid Artery Stenting.
    Fujita J; Hirotsune N; Matsuda Y; Hamasaki O; Fukuda S; Okada Y; Kobashi A; Nishigaki S; Makino K; Tomita Y; Kidani N; Muraoka K; Nishino S
    Neurol Med Chir (Tokyo); 2024 Oct; 64(10):382-386. PubMed ID: 39198155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
    Safian RD
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):84-5. PubMed ID: 27400638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):73-83. PubMed ID: 26482020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.